Patients with rheumatoid arthritis in clinical care

被引:58
|
作者
Smolen, JS
Aletaha, D
机构
[1] Univ Vienna, Vienna Gen Hosp Vienna, Dept Internal Med 3, Div Rheumatol, A-1090 Vienna, Austria
[2] Lainz Hosp, Dept Med 2, Vienna, Austria
关键词
D O I
10.1136/ard.2003.012575
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Taken together, our current clinical armamentarium to follow the course of RA offers several disease activity measures. Evaluation of radiographic destruction, but also of anatomical changes such as malalignment,77 can serve as outcome measure, because these changes best reflect the damage related to the pathological process in and around the joints; whether radiological changes can be reversible, is still a matter of debate. 78 Assessment of function reflects the combination of disease activity and damage. Questionnaires or other instruments which only determine functional improvement due to irreversible damage are not (yet) available. However, their development could lead to interesting, new clinical insights. Likewise, basic science has not yet provided us with tests that reflect the destructive process reliably. Measuring disease activity by surrogate measures such as the acute phase proteins does not reflect destruction at a single point in time. In conclusion, assessment of disease activity, damage, and functional capacity are equally important also in clinical practice; RA, if insufficiently controlled, may be a highly destructive disease. Achieving low disease activity, ideally a remission-like state, is pivotal to improving prognosis. 79 Current treatments and early institution of DMARDs allow this aim to be accomplished in many patients. However, decisions to switch (or to maintain) treatment require recording of the patients' clinical status, and in many healthcare systems the use of costly treatments, as increasingly employed, requires justification which, again, can only come from recorded data. 18 Rather than guessing disease activity and quality of life, providing evidence will validate decisions and improve quality of care. A combination of a more physician centred activity score, such as the SDAI or similar, with a patient centred functional measure, such as the HAQ or similar, in conjunction with an occasional evaluation of the radiographic situation, will give all necessary information for the longitudinal observation of patients' disease state in clinical practice. The tools are available and so relatively easy to use.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [41] EVALUATING QUALITY OF CARE IN RHEUMATOID ARTHRITIS: PATIENTS PERSPECTIVE
    Mahmood, S.
    van Oosterhout, M.
    de Jong, S.
    Landewe, R.
    van Riel, P.
    van Tuyl, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 888 - 888
  • [42] Clinical impact of musculoskeletal ultrasound on rheumatoid arthritis in routine care
    Molina Collada, Juan
    Castrejon, Isabel
    Perez, Maria
    Nieto-Gonzalez, Juan Carlos
    Gonzalez, Teresa
    Rivera, Javier
    Gonzalez, Carlos
    Alvaro-Gracia, Jose Maria
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (03) : 341 - 346
  • [43] Identification of the pharmaceutical care issues of rheumatoid arthritis patients in secondary care
    O'Hare, R
    Muir, A
    Chapman, S
    Watson, A
    Hudson, SA
    PHARMACY WORLD & SCIENCE, 2001, 23 (05): : 183 - 184
  • [44] Variations and Practice in the Care of Patients With Rheumatoid Arthritis Quality and Cost of Care
    DeMaria, Lisa
    Acelajado, Maria Czarina
    Luck, Jeff
    Ta, Hui
    Chernoff, David
    Florentino, Jhiedon
    Peabody, John W.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (02) : 79 - 86
  • [45] Quality of care of rural rheumatoid arthritis patients in Austria
    Puchner, Rudolf
    Brezinschek, Hans Peter
    Herold, Manfred
    Nothnagl, Thomas
    Studnicka-Benke, Andrea
    Fritz, Josef
    Leeb, Burkhard F.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 (11-12) : 360 - 367
  • [46] COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN AN INDIGENOUS CARE CLINIC
    Santoyo Fexas, Leticia
    Garza Elizondo, C. Mario Alberto
    Elizondo Solis, Cesar Vidal
    Moreno Salinas, Andrea
    Castaneda Martinez, Martha Mariana
    Galarza Delgado, Med. Dionicio Angel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 65 - 65
  • [47] Remote pharmaceutical care for patients with rheumatoid arthritis and psoriasis
    Martinez-Santana, V.
    Boix-Montanes, A.
    Fernandez-Canabate, E.
    Gonzalez-Melarde, B.
    Miserachs-Aranda, N.
    Modamio-Charles, P.
    Fernandez-Lastra, C.
    Marino-Hernandez, E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (04) : 938 - 947
  • [48] In-office imaging in the care of patients with rheumatoid arthritis
    John T Sharp
    Nature Clinical Practice Rheumatology, 2005, 1 : 64 - 65
  • [49] Identification of the pharmaceutical care issues of rheumatoid arthritis patients in secondary care
    R. O'Hare
    A. Muir
    S. Chapman
    A. Watson
    S.A. Hudson
    Pharmacy World and Science, 2001, 23 : 183 - 184
  • [50] Quantitative measures and indices to assess rheumatoid arthritis in clinical trials and clinical care
    Pincus, T
    Sokka, T
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (04) : 725 - +